Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$43.23 - $73.83 $3,804 - $6,497
-88 Closed
0 $0
Q4 2021

Jan 26, 2022

BUY
$70.09 - $111.29 $6,167 - $9,793
88 New
88 $7,000
Q2 2021

Jul 22, 2021

SELL
$100.84 - $161.89 $8,873 - $14,246
-88 Closed
0 $0
Q1 2021

Apr 20, 2021

BUY
$110.72 - $210.04 $9,743 - $18,483
88 New
88 $11,000
Q4 2020

Jan 26, 2021

SELL
$79.67 - $173.23 $7,010 - $15,244
-88 Closed
0 $0
Q3 2020

Oct 21, 2020

BUY
$78.5 - $100.64 $6,908 - $8,856
88 New
88 $7,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.24B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Northwest Investment Counselors, LLC Portfolio

Follow Northwest Investment Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Investment Counselors, LLC with notifications on news.